Ann Liver Transplant.  2022 Nov;2(2):107-111. 10.52604/alt.22.0021.

Graft-versus-host disease after living donor liver transplantation: A collective review of Korean cases

• Park JI
• Chung YK

• KMID: 2560903
• DOI: http://doi.org/10.52604/alt.22.0021

Abstract

Graft-versus-host disease (GVHD) occurs when donor lymphocytes recognize recipient cell surface antigens as foreign and react against them. Although GVHD is rare, it is a life-threatening complication. Following liver transplantation (LT), the incidence of GVHD is estimated to be 0.1% to 2%. However, more than 50% of affected patients have died. Living donor LT (LDLT) has a special risk of GVHD because implicating human leukocyte antigen (HLA) matching status between recipients and close-relative living donors. Therefore, we reviewed Korean GVHD cases following LDLT to identify LDLT-oriented characteristics of GVHD. This study included one case from each of three centers and three cases from one high-volume center. One-way donor-recipient HLA match was identified by HLA typing for donor and recipient. Of these six cases of LDLT diagnosed with GVHD, all patients died due to GVHD and its associated complications. In conclusion, post-LT GVHD is a fatal complication despite aggressive treatment approaches. Preventive measures, early diagnosis, early initiation of treatment protocols, prophylactic treatment, and appropriate palliative care are necessary to achieve success against GVHD. Further studies should be performed to reveal the mechanisms of GVHD and improve outcomes of patients who develop GVHD following LT.

Keyword

Graft-versus-host disease; Liver transplantation; Diarrhea; Skin rash; Human leukocyte antigen

Reference

1. Rai V, Dietz NE, Agrawal DK. 2016; Immunological basis for treatment of graft versus host disease after liver transplant. Expert Rev Clin Immunol. 12:583–593. DOI: 10.1586/1744666X.2016.1145056. PMID: 26795873. PMCID: PMC4955803.

2. Akbulut S, Yilmaz M, Yilmaz S. 2012; Graft-versus-host disease after liver transplantation: a comprehensive literature review. World J Gastroenterol. 18:5240–5248.

3. Kang WH, Hwang S, Song GW, Jung DH, Park GC, Ahn CS, et al. 2016; Acute graft-vs-host disease after liver transplantation: experience at a high-volume liver transplantation center in Korea. Transplant Proc. 48:3368–3372. DOI: 10.1016/j.transproceed.2016.08.051. PMID: 27931583.

4. Murali AR, Chandra S, Stewart Z, Blazar BR, Farooq U, Ince MN, et al. 2016; Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management. Transplantation. 100:2661–2670. DOI: 10.1097/TP.0000000000001406. PMID: 27495762. PMCID: PMC5118135.

5. Kakotrichi A, Hind J. 2017; Graft-versus-host disease in paediatric liver transplantation: a review of the literature. S Afr Med J. 107:12133.

6. Taylor AL, Gibbs P, Bradley JA. 2004; Acute graft versus host disease following liver transplantation: the enemy within. Am J Transplant. 4:466–474. DOI: 10.1111/j.1600-6143.2004.00406.x. PMID: 15023138.

7. Schulman JM, Yoon C, Schwarz J, Vagefi PA, Mully TW, Shinkai K. 2014; Absence of peripheral blood chimerism in graft-vs-host disease following orthotopic liver transplantation: case report and review of the literature. Int J Dermatol. 53:e492–e498. DOI: 10.1111/ijd.12149. PMID: 24372059. PMCID: PMC4441623.

8. Yilmaz M, Ozdemir F, Akbulut S, Ersan V, Koc C, Koc S, et al. 2012; Chronic graft-versus-host disease after liver transplantation: a case report. Transplant Proc. 44:1751–1753. DOI: 10.1016/j.transproceed.2012.05.036. PMID: 22841262.

9. Elfeki MA, Pungpapong S, Genco PV, Nakhleh RE, Nguyen JH, Harnois DM. 2015; Graft-versus-host disease after orthotopic liver transplantation: multivariate analysis of risk factors. Clin Transplant. 29:1063–6. DOI: 10.1111/ctr.12627. PMID: 26358521.

10. Chen XB, Yang J, Xu MQ, Wen TF, Yan LN. 2012; Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World J Gastroenterol. 18:84–89. DOI: 10.3748/wjg.v18.i1.84. PMID: 22228975. PMCID: PMC3251810.

11. Cho EH, Suh KS, Yang SH, Lee HW, Cho JY, Cho YB, et al. 2007; Acute graft versus host disease following living donor liver transplantation: first Korean report. Hepatogastroenterology. 54:2120–2122.

12. Yu YD, Kim DS, Ha N, Jung SW, Han JH, Kim JY, et al. 2016; Fatal graft-versus-host disease following adult-to-adult living donor liver transplantation from an HLA nonhomozygous donor. Prog Transplant. 26:394–396. DOI: 10.1177/1526924816664087. PMID: 27555077.

13. Kim KJ, Lee TB, Yang KH, Ryu JH, Choi BH, Lee HJ, et al. 2019; Temporary cessation of immunosuppression for infection may contribute to the development of graft-vs-host disease after ABO-incompatible living donor liver transplantation: a case report. Transplant Proc. 51:3136–3139. DOI: 10.1016/j.transproceed.2019.07.008. PMID: 31611115.

14. Burdick JF, Vogelsang GB, Smith WJ, Farmer ER, Bias WB, Kaufmann SH, et al. 1988; Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med. 318:689–691. DOI: 10.1056/NEJM198803173181107. PMID: 3278235.

15. Taylor AL, Gibbs P, Sudhindran S, Key T, Goodman RS, Morgan CH, et al. 2004; Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation. Transplantation. 77:441–446. DOI: 10.1097/01.TP.0000103721.29729.FE. PMID: 14966423.

16. Triulzi DJ, Shirey RS, Ness PM, Klein AS. 1992; Immunohematologic complications of ABO-unmatched liver transplants. Transfusion. 32:829–833. DOI: 10.1046/j.1537-2995.1992.32993110754.x. PMID: 1471246.

17. Norris S, Collins C, Doherty DG, Smith F, McEntee G, Traynor O, et al. 1998; Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol. 28:84–90. DOI: 10.1016/S0168-8278(98)80206-7. PMID: 9537869.

18. Schrager JJ, Vnencak-Jones CL, Graber SE, Neff AT, Chari RS, Wright KJ Jr, et al. 2006; Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients. Transplantation. 81:21–25. DOI: 10.1097/01.tp.0000190431.94252.3f. PMID: 16421472.

19. Hirata M, Yagi S, Shindo T, Yoshizawa A, Kiguchi G, Kaneshiro M, et al. 2021; Donor-dominant one-way matching of human leukocyte antigen-A/B/DR alleles predicts graft-versus-host disease following living donor liver transplantation. Hepatol Res. 51:135–148. DOI: 10.1111/hepr.13579. PMID: 33034106.

20. Soejima Y, Shimada M, Suehiro T, Hiroshige S, Gondo H, Takami A, et al. 2004; Graft-versus-host disease following living donor liver transplantation. Liver Transpl. 10:460–464. DOI: 10.1002/lt.20101. PMID: 15004778.

21. Kamei H, Oike F, Fujimoto Y, Yamamoto H, Tanaka K, Kiuchi T. 2006; Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching. Liver Transpl. 12:140–145. DOI: 10.1002/lt.20573. PMID: 16382466.

22. Shimizu T, Hayashi M, Inoue Y, Komeda K, Asakuma M, Hirokawa F, et al. 2010; Acute graft-versus-host disease after living donor liver transplantation with donor-dominant one-way human leukocyte antigen matching at two Loci. Transplantation. 89:1164–1166. DOI: 10.1097/TP.0b013e3181cea646. PMID: 20440198.

23. Shimata K, Sakamoto R, Anan T, Uchida K, Honda M, Kouroki M, et al. 2017; Fatal graft-versus-host disease after living-donor liver transplantation from an HLA-DR-mismatched donor. Pediatr Transplant. 21:e13039. DOI: 10.1111/petr.13039. PMID: 28834141.

24. Uchida S, Tadokoro K, Takahashi M, Yahagi H, Satake M, Juji T. 2013; Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood. Transfus Med. 23:416–422. DOI: 10.1111/tme.12081. PMID: 24274074.